AARD
Aardvark Therapeutics, Inc. · Healthcare
Decheng Capital Global Life Sciences Fund Iv, L.P. bought $20.0M of Aardvark Therapeutics, Inc.
10% owner
Bought$20,000,000
$16.00Price
1,250,000Shares
+47%Stake
What AARD did for a copier
- $1,000 copied at Wed, Feb 19 close, $14.90
- $628
- S&P 500, same days
- −7.6%
Measured over 30 trading days, to the Apr 2 close.
Decheng Capital Global Life Sciences Fund Iv, L.P.'s record
1 other buy on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Fri, Feb 14. Filed Wed, Feb 19, 12:44 PM ET, during the session. Returns use the Feb 19 close and the Apr 2 close. Not investment advice.